Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 0 | 0 | 26,024 |
| Cost of Goods | N/A | N/A | N/A | N/A | 393 |
| Gross Profit | N/A | N/A | N/A | N/A | 25,631 |
| Operating Expenses | 80,290 | 83,264 | 87,030 | -86,607 | 135,084 |
| Operating Income | -80,290 | -83,264 | -87,030 | 4,135 | -109,060 |
| Other Income | 1,115 | 1,769 | 2,936 | 3,579 | 2,887 |
| Pre-tax Income | -79,175 | -81,495 | -84,094 | 7,714 | -106,173 |
| Net Income Continuous | -79,175 | -81,495 | -84,094 | 7,714 | -106,173 |
| Net Income Discontinuous | -19,804 | -8,983 | 43,838 | N/A | N/A |
| Net Income | $-98,979 | $-90,478 | $-40,256 | $-102,350 | $-106,173 |
| EPS Basic Total Ops | -1.43 | -1.31 | -0.59 | -1.59 | -1.81 |
| EPS Basic Continuous Ops | -1.15 | -1.18 | -1.23 | 0.25 | -1.81 |
| EPS Basic Discontinuous Ops | -0.29 | -0.13 | 0.64 | N/A | N/A |
| EPS Diluted Total Ops | -1.43 | -1.31 | -0.59 | -1.59 | -1.81 |
| EPS Diluted Continuous Ops | -1.15 | -1.18 | -1.23 | 0.25 | -1.81 |
| EPS Diluted Discontinuous Ops | -0.29 | -0.13 | 0.64 | N/A | N/A |
| EBITDA(a) | $-76,927 | $-80,504 | $-84,430 | $88,148 | $-107,731 |